Clinical trial
Testing the Reliability of IQ Tests in Various Populations As a Result of Fluctuating Brain Plasticity, Administered Racetam-Class Drugs, Intelligence Placebos, Daily Energy Levels, and Modafinil
NCT07852130 is registered in ClinicalTrials.gov with Abdulraheem Mohamed Gouda as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Testing the Reliability of IQ Tests in Various Populations As a Result of Fluctuating Brain Plasticity, Administered Racetam-Class Drugs, Intelligence Placebos, Daily Energy Levels, and Modafinil
- Lead sponsor
- Abdulraheem Mohamed Gouda
- Phase
- Phase 1
- Overall status
- Completed
- Start date
- March 9, 2026
- Completion date
- September 12, 2026
- Enrollment
- 70 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
cognition, healthy, sleep deprivation